Celsion (CLSN) Says ThermoDox Missed Primary Endpoint in Phase III HEAT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/18/2024
- Stocks decline as interest rate uncertainty, earnings weigh
- ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
- US dollar weakens as market consolidates gains, but uptrend intact
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Stocks have priced in much of the 2024 optimism - Wells Fargo
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Crude Inventory Rose 2.7 Million Barrels Last Week, Says EIA
- Lithium Americas Corp (LAC) Announces Proposed 55M Share Offering
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
Roth Capital Downgrades Celsion Corp (CLSN) to Neutral
January 31, 2013 2:57 PM ESTEarlier, Roth Capital downgraded Celsion Corp (NASDAQ: CLSN) from Buy to Neutral with a price target of $1.70 (from $10.00) following today's trial failure.
For an analyst ratings summary and ratings history on Celsion Corp click here. For more ratings news on Celsion Corp click here.
Shares of Celsion are down 81% to $1.52.... More
Celsion (CLSN) will resume trading at 7:30AM after Trial Failure
January 31, 2013 7:27 AM ESTCelsion Corporation (NASDAQ: CLSN) will resume trading at 7:30AM ThermoDox Missed Primary Endpoint in Phase III HEAT... More
Celsion (CLSN) to Hold Phase III HEAT Call on Jan. 31; Receives Priority Trial Designation
January 30, 2013 4:15 PM ESTCelsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that it will host a conference call and webcast at 8:00 a.m. Eastern Time on Thursday, January 31, 2013 to present the top-line results from its pivotal Phase III HEAT Study with ThermoDox® in combination... More
Celsion (CLSN) trading halted with news pending
January 30, 2013 4:03 PM ESTCelsion Corporation (NASDAQ: CLSN) trading halted with news pending.... More
